{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:24:35Z","timestamp":1794266675987,"version":"4.9.0"},"reference-count":84,"publisher":"Bentham Science Publishers Ltd.","issue":"10","funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG050253"],"award-info":[{"award-number":["R01AG050253"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2020,1,17]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Lithium as a mood stabilizer has been used as the standard pharmacological treatment for\nBipolar Disorder (BD) for more than 60 years. Recent studies have also shown that it has the potential\nfor the treatment of many other neurodegenerative disorders, including Alzheimer\u2019s, Parkinson\u2019s and\nHuntington\u2019s disease, through its neurotrophic, neuroprotective, antioxidant and anti-inflammatory actions.\nTherefore, exploring its pharmacokinetic features and designing better lithium preparations are\nbecoming important research topics. We reviewed many studies on the pharmacokinetics, drug design\nand toxicity of lithium based on recent relevant research from PubMed, Web of Science, Elsevier and\nSpringer databases. Keywords used for searching references were lithium, pharmacology, pharmacokinetics,\ndrug design and toxicity. Lithium is rapidly and completely absorbed from the gastrointestinal\ntract after oral administration. Its level is initially highest in serum and then is evidently redistributed\nto various tissue compartments. It is not metabolized and over 95% of lithium is excreted unchanged\nthrough the kidney, but different lithium preparations may have different pharmacokinetic\nfeatures. Lithium has a narrow therapeutic window limited by various adverse effects, but some novel\ndrugs of lithium may overcome these problems. Various formulations of lithium have the potential for\ntreating neurodegenerative brain diseases but further study on their pharmacokinetics will be required\nin order to determine the optimal formulation, dosage and route of administration.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871527318666191114095249","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T08:30:39Z","timestamp":1573720239000},"page":"769-778","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["A Review for Lithium: Pharmacokinetics, Drug Design, and Toxicity"],"prefix":"10.2174","volume":"18","author":[{"given":"Jinhua","family":"Wen","sequence":"first","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of Nanchang University, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell","family":"Sawmiller","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Wheeldon","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neurosciences, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1399-5618.2009.00706.x","volume":"11","author":"Shorter E.","year":"2009","unstructured":"Shorter E.; The history of lithium therapy. Bipolar Disord 2009,11(Suppl. 2),4-9","journal-title":"Bipolar Disord"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ejphar.2014.06.042","volume":"740","author":"Oruch R.","year":"2014","unstructured":"Oruch R.; Elderbi M.A.; Khattab H.A.; Pryme I.F.; Lund A.; Lithium: A review of pharmacology, clinical uses, and toxicity. Eur J Pharmacol 2014,740,464-473","journal-title":"Eur J Pharmacol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3727\/096368909X471251","volume":"18","author":"Young W.","year":"2009","unstructured":"Young W.; Review of lithium effects on brain and blood. Cell Transplant 2009,18(9),951-975","journal-title":"Cell Transplant"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1080\/17425255.2017.1386653","volume":"13","author":"Richardson T.","year":"2017","unstructured":"Richardson T.; Macaluso M.; Clinically relevant treatment considerations regarding lithium use in bipolar disorder. Expert Opin Drug Metab Toxicol 2017,13(11),1105-1113","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2165\/00023210-200923050-00004","volume":"23","author":"Grandjean E.M.","year":"2009","unstructured":"Grandjean E.M.; Aubry J.M.; Lithium: Updated human knowledge using an evidence-based approach: Part III: Clinical safety. CNS Drugs 2009,23(5),397-418","journal-title":"CNS Drugs"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/1871527317666181105093834","volume":"18","author":"Zhao J.","year":"2019","unstructured":"Zhao J.; Zhu M.; Kumar M.; A pharmacological appraisal of neuroprotective and neurorestorative flavonoids against neurodegenerative diseases. CNS Neurol Disord Drug Targets 2019,18(2),103-114","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2174\/1871527317666180828120256","volume":"17","author":"Mazza M.","year":"2018","unstructured":"Mazza M.; Marano G.; Traversi G.; Carocci V.; Romano B.; Janiri L.; Cariprazine in bipolar depression and mania: State of the art. CNS Neurol Disord Drug Targets 2018,17(10),723-727","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"714","DOI":"10.2174\/1871527316666170223162747","volume":"16","year":"2017","unstructured":"D Alessandro J, Garofalo K, Zhao G, et al. Demonstration of biological and immunological equivalence of a generic glatiramer acetate. CNS Neurol Disord Drug Targets 2017,16(6),714-723","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF01869189","volume":"52","author":"Ehrlich B.E.","year":"1980","unstructured":"Ehrlich B.E.; Diamond J.M.; Lithium, membranes, and manic-depressive illness. J Membr Biol 1980,52(3),187-200","journal-title":"J Membr Biol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1365-2125.1988.tb03316.x","volume":"25","author":"Hunter R.","year":"1988","unstructured":"Hunter R.; Steady-state pharmacokinetics of lithium carbonate in healthy subjects. Br J Clin Pharmacol 1988,25(3),375-380","journal-title":"Br J Clin Pharmacol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1046\/j.1365-2125.2000.00248.x","volume":"50","author":"Chen C.","year":"2000","unstructured":"Chen C.; Veronese L.; Yin Y.; The effects of lamotrigine on the pharmacokinetics of lithium. Br J Clin Pharmacol 2000,50(3),193-195","journal-title":"Br J Clin Pharmacol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/S0140-6736(74)90114-7","volume":"2","author":"Carman J.S.","year":"1974","unstructured":"Carman J.S.; Post R.M.; Teplitz T.A.; Goodwin F.K.; Letter: Divalent cations in predicting antidepressant response to lithium. Lancet 1974,2(7894),1454","journal-title":"Lancet"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/00048679809062720","volume":"32","author":"Lee C.F.","year":"1998","unstructured":"Lee C.F.; Yang Y.Y.; Hu O.Y.; Single dose pharmacokinetic study of lithium in Taiwanese\/Chinese bipolar patients. Aust N Z J Psychiatry 1998,32(1),133-136","journal-title":"Aust N Z J Psychiatry"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/00004850-198710000-00007","volume":"2","author":"Shelley R.K.","year":"1987","unstructured":"Shelley R.K.; Are there ethnic differences in lithium pharmacokinetics and side-effects? Int Clin Psychopharmacol 1987,2(4),337-342","journal-title":"Int Clin Psychopharmacol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1166\/jnn.2011.3913","volume":"11","author":"Wungu T.D.","year":"2011","unstructured":"Wungu T.D.; Aspera S.M.; David M.Y.; Dipojono H.K.; Nakanishi H.; Kasai H.; Absorption of lithium in montmorillonite: A density functional theory (DFT) study. J Nanosci Nanotechnol 2011,11(4),2793-2801","journal-title":"J Nanosci Nanotechnol"},{"key":"ref=16","first-page":"86","volume":"43","author":"Ponampalam R.","year":"2002","unstructured":"Ponampalam R.; Otten E.J.; \n                        In vitro adsorption of lithium by bentonite. Singapore Med J 2002,43(2),86-89","journal-title":"Singapore Med J"},{"key":"ref=17","first-page":"1176","volume":"46","author":"Moosavi M.","year":"2017","unstructured":"Moosavi M.; Bentonite clay as a natural remedy: A brief review. Iran J Public Health 2017,46(9),1176-1183","journal-title":"Iran J Public Health"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3109\/15563658809038560","volume":"26","author":"Favin F.D.","year":"1988","unstructured":"Favin F.D.; Klein-Schwartz W.; Oderda G.M.; Rose S.R.; \n                        In vitro study of lithium carbonate adsorption by activated charcoal. J Toxicol Clin Toxicol 1988,26(7),443-450","journal-title":"J Toxicol Clin Toxicol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/j.1552-4604.1994.tb01994.x","volume":"34","author":"Ward M.E.","year":"1994","unstructured":"Ward M.E.; Musa M.N.; Bailey L.; Clinical pharmacokinetics of lithium. J Clin Pharmacol 1994,34(4),280-285","journal-title":"J Clin Pharmacol"},{"key":"ref=20","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.279","volume":"8","author":"Habib A.","year":"2017","unstructured":"Habib A.; Sawmiller D.; Li S.; LISPRO mitigates \u03b2-amyloid and associated pathologies in Alzheimer\u2019s mice. Cell Death Dis 2017,8(6)","journal-title":"Cell Death Dis"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neulet.2012.05.060","volume":"521","author":"Hillert M.","year":"2012","unstructured":"Hillert M.; Zimmermann M.; Klein J.; Uptake of lithium into rat brain after acute and chronic administration. Neurosci Lett 2012,521(1),62-66","journal-title":"Neurosci Lett"},{"key":"ref=22","first-page":"5","volume":"61","author":"Lenox R.H.","year":"2000","unstructured":"Lenox R.H.; Hahn C.G.; Overview of the mechanism of action of lithium in the brain: Fifty-year update. J Clin Psychiatry 2000,61(Suppl. 9),5-15","journal-title":"J Clin Psychiatry"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.celrep.2014.03.054","volume":"7","author":"Milosavljevic N.","year":"2014","unstructured":"Milosavljevic N.; Monet M.; L\u00e9na I.; The intracellular Na(+)\/H(+) exchanger NHE7 effects a Na(+)-coupled, but not K(+)-coupled proton-loading mechanism in endocytosis. Cell Rep 2014,7(3),689-696","journal-title":"Cell Rep"},{"key":"ref=24","first-page":"317","volume":"40","author":"Maletzky B.M.","year":"1979","unstructured":"Maletzky B.M.; Enhancing the efficacy of lithium treatment by combined use with diuretics and low sodium diets: A preliminary report. J Clin Psychiatry 1979,40(7),317-322","journal-title":"J Clin Psychiatry"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/acps.12511","volume":"133","author":"Machado-Vieira R.","year":"2016","unstructured":"Machado-Vieira R.; Otaduy M.C.; Zanetti M.V.; A selective association between central and peripheral lithium levels in remitters in bipolar depression: A 3T-(7) Li magnetic resonance spectroscopy study. Acta Psychiatr Scand 2016,133(3),214-220","journal-title":"Acta Psychiatr Scand"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s11095-008-9612-5","volume":"25","author":"Sakae R.","year":"2008","unstructured":"Sakae R.; Ishikawa A.; Niso T.; Decreased lithium disposition to cerebrospinal fluid in rats with glycerol-induced acute renal failure. Pharm Res 2008,25(10),2243-2249","journal-title":"Pharm Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/toxsci\/kfu224","volume":"143","author":"Hanak A.S.","year":"2015","unstructured":"Hanak A.S.; Chevillard L.; El Balkhi S.; Risede P.; Peoc\u2019h K.; Megarbane B.; Study of blood and brain lithium pharmacokinetics in the rat according to three different modalities of poisoning. Toxicol Sci 2015,143(1),185-195","journal-title":"Toxicol Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.bpc.2007.05.003","volume":"129","author":"Suwalsky M.","year":"2007","unstructured":"Suwalsky M.; Fierro P.; Villena F.; Sotomayor C.P.; Effects of lithium on the human erythrocyte membrane and molecular models. Biophys Chem 2007,129(1),36-42","journal-title":"Biophys Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5414\/CPP41200","volume":"41","author":"Arancibia A.","year":"2003","unstructured":"Arancibia A.; Paulos C.; Ch\u00e1vez J.; Ritschel W.A.; Pharmacokinetics of lithium in healthy volunteers after exposure to high altitude. Int J Clin Pharmacol Ther 2003,41(5),200-206","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1399-5618.2007.00438.x","volume":"9","author":"Wilting I.","year":"2007","unstructured":"Wilting I.; Fase S.; Martens E.P.; Heerdink E.R.; Nolen W.A.; Egberts A.C.; The impact of environmental temperature on lithium serum levels. Bipolar Disord 2007,9(6),603-608","journal-title":"Bipolar Disord"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3109\/08039488.2011.650198","volume":"66","author":"Nielsen R.E.","year":"2012","unstructured":"Nielsen R.E.; Damkier P.; Pharmacological treatment of unipolar depression during pregnancy and breast-feeding--a clinical overview. Nord J Psychiatry 2012,66(3),159-166","journal-title":"Nord J Psychiatry"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00737-012-0257-3","volume":"15","author":"Bogen D.L.","year":"2012","unstructured":"Bogen D.L.; Sit D.; Genovese A.; Wisner K.L.; Three cases of lithium exposure and exclusive breastfeeding. Arch Women Ment Health 2012,15(1),69-72","journal-title":"Arch Women Ment Health"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1364\/BOE.9.004459","volume":"9","author":"Ahmed I.","year":"2018","unstructured":"Ahmed I.; Yang J.; Law A.W.L.; Rapid and in situ optical detection of trace lithium in tissues. Biomed Opt Express 2018,9(9),4459-4471","journal-title":"Biomed Opt Express"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJM199409013310907","volume":"331","author":"Price L.H.","year":"1994","unstructured":"Price L.H.; Heninger G.R.; Lithium in the treatment of mood disorders. N Engl J Med 1994,331(9),591-598","journal-title":"N Engl J Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1515\/dmdi-2014-0033","volume":"30","author":"Uwai Y.","year":"2015","unstructured":"Uwai Y.; Kawasaki T.; Nabekura T.; Minor contribution of biliary excretion in lithium elimination in rats. Drug Metab Pers Ther 2015,30(1),65-67","journal-title":"Drug Metab Pers Ther"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1365-2125.1996.tb00174.x","volume":"41","author":"Brager N.P.","year":"1996","unstructured":"Brager N.P.; Campbell N.R.; Reisch H.; Chaudhuri M.; Rabin H.R.; Reduced renal fractional excretion of lithium in cystic fibrosis. Br J Clin Pharmacol 1996,41(2),157-159","journal-title":"Br J Clin Pharmacol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1136\/bmj.305.6864.1273","volume":"305","author":"Aronson J.K.","year":"1992","unstructured":"Aronson J.K.; Reynolds D.J.; ABC of monitoring drug therapy. Lithium. BMJ 1992,305(6864),1273-1276","journal-title":"BMJ"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/0006-3223(94)00243-V","volume":"37","author":"Mester R.","year":"1995","unstructured":"Mester R.; Toren P.; Mizrachi I.; Wolmer L.; Karni N.; Weizman A.; Caffeine withdrawal increases lithium blood levels. Biol Psychiatry 1995,37(5),348-350","journal-title":"Biol Psychiatry"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1042\/cs1030461","volume":"103","author":"Shirley D.G.","year":"2002","unstructured":"Shirley D.G.; Walter S.J.; Noormohamed F.H.; Natriuretic effect of caffeine: Assessment of segmental sodium reabsorption in humans. Clin Sci (Lond) 2002,103(5),461-466","journal-title":"Clin Sci (Lond)"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2174\/1871527316666170303144817","volume":"16","author":"Caraci F.","year":"2017","unstructured":"Caraci F.; Sultana J.; Drago F.; Spina E.; Clinically relevant drug interactions with anti-Alzheimer\u2019s drugs. CNS Neurol Disord Drug Targets 2017,16(4),501-513","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2174\/1871527316666170413104516","volume":"16","author":"Arellano A.L.","year":"2017","unstructured":"Arellano A.L.; Papaseit E.; Romaguera A.; Torrens M.; Farr\u00e9 M.; Neuropsychiatric and general interactions of natural and synthetic Cannabinoids with drugs of abuse and medicines. CNS Neurol Disord Drug Targets 2017,16(5),554-566","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2165\/11599180-000000000-00000","volume":"29","author":"Forlenza O.V.","year":"2012","unstructured":"Forlenza O.V.; de Paula V.J.; Machado-Vieira R.; Diniz B.S.; Gattaz W.F.; Does lithium prevent Alzheimer\u2019s disease? Drugs Aging 2012,29(5),335-342","journal-title":"Drugs Aging"},{"key":"ref=43","first-page":"338","volume":"7","author":"Emami J.","year":"2004","unstructured":"Emami J.; Tavakoli N.; Movahedian A.; Formulation of sustained - release lithium carbonate matrix tablets: Influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation. J Pharm Pharm Sci 2004,7(3),338-344","journal-title":"J Pharm Pharm Sci"},{"key":"ref=44","first-page":"656","volume":"2","author":"Haddad L.M.","year":"1990","unstructured":"Haddad L.M.; Winchester J.F.;  Clinical management of poisoning and drug overdose 2nd ed. Philadelphia, PA: WB Saunders;1990,2,656-665","journal-title":"Clinical management of poisoning and drug overdose"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1600-0447.1974.tb08206.x","volume":"50","author":"Persson G.","year":"1974","unstructured":"Persson G.; Plasma lithium levels and side effects during administration of a slow release lithium sulphate preparation (Lithium lipett C) and lithium carbonate tablets. Acta Psychiatr Scand 1974,50(2),174-182","journal-title":"Acta Psychiatr Scand"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1055\/s-2007-1014360","volume":"26","author":"Kolk A.","year":"1993","unstructured":"Kolk A.; Kathmann N.; Greil W.; No short-term changes of cognitive performance and mood after single doses of two different lithium retard preparations. Pharmacopsychiatry 1993,26(6),235-239","journal-title":"Pharmacopsychiatry"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1254\/fpj.72.433","volume":"72","author":"Ozawa H.","year":"1976","unstructured":"Ozawa H.; Nozu T.; Aihara H.; Akiyama F.; Sasajima M.; [Pharmacokinetics and general pharmacological actions of lithium salts administered singly or repeatedly Nippon Yakurigaku Zasshi 1976,72(4),433-443","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1476-5381.1976.tb07449.x","volume":"56","author":"Smith D.F.","year":"1976","unstructured":"Smith D.F.; Lithium orotate, carbonate and chloride: pharmacokinetics, polydipsia and polyuria in rats. Br J Pharmacol 1976,56(4),399-402","journal-title":"Br J Pharmacol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/BF00561406","volume":"12","author":"Altamura A.C.","year":"1977","unstructured":"Altamura A.C.; Gomeni R.; Sacchetti E.; Smeraldi E.; Plasma and intracellular kinetics of lithium after oral administration of various lithium salts. Eur J Clin Pharmacol 1977,12(1),59-63","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=50","doi-asserted-by":"publisher","DOI":"10.1177\/0004867418810185","author":"Devadason P.","year":"2018","unstructured":"Devadason P.; Is there a role for lithium orotate in psychiatry? Aust N Z J Psychiatry 2018","journal-title":"Aust N Z J Psychiatry"},{"key":"ref=51","first-page":"407","volume":"14","author":"Nieper H.A.","year":"1973","unstructured":"Nieper H.A.; The clinical applications of lithium orotate. A two years study. Agressologie 1973,14(6),407-411","journal-title":"Agressologie"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.2042-7158.1978.tb13258.x","volume":"30","author":"Kling M.A.","year":"1978","unstructured":"Kling M.A.; Manowitz P.; Pollack I.W.; Rat brain and serum lithium concentrations after acute injections of lithium carbonate and orotate. J Pharm Pharmacol 1978,30(6),368-370","journal-title":"J Pharm Pharmacol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.2042-7158.1979.tb13461.x","volume":"31","author":"Smith D.F.","year":"1979","unstructured":"Smith D.F.; Schou M.; Kidney function and lithium concentrations of rats given an injection of lithium orotate or lithium carbonate. J Pharm Pharmacol 1979,31(3),161-163","journal-title":"J Pharm Pharmacol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"12362","DOI":"10.1039\/C3RA46962J","volume":"4","author":"Smith A.J.","year":"2014","unstructured":"Smith A.J.; Kim S.H.; Tan J.; Plasma and brain pharmacokinetics of previously unexplored lithium salts. RSC Advances 2014,4(24),12362-12365","journal-title":"RSC Advances"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1023\/A:1015863204732","volume":"7","author":"Cift\u00e7i K.","year":"1990","unstructured":"Cift\u00e7i K.; Capan Y.; Ozt\u00fcrk O.; Hincal A.A.; Formulation and in vitro-in vivo evaluation of sustained-release lithium carbonate tablets. Pharm Res 1990,7(4),359-363","journal-title":"Pharm Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1590\/S1516-44462002000200007","volume":"24","author":"Vismari L.","year":"2002","unstructured":"Vismari L.; Pires M.L.N.; Benedito-Silva A.A.; Calil H.M.; Bioavailability of immediate and controlled release formulations of lithium carbonate. Rev Bras Psiquiatr 2002,24(2),74-79","journal-title":"Rev Bras Psiquiatr"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1021\/mp400571a","volume":"10","author":"Smith A.J.","year":"2013","unstructured":"Smith A.J.; Kim S.H.; Duggirala N.K.; Improving lithium therapeutics by crystal engineering of novel ionic cocrystals. Mol Pharm 2013,10(12),4728-4738","journal-title":"Mol Pharm"},{"key":"ref=58","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.169","volume":"7","author":"Wilson E.N.","year":"2017","unstructured":"Wilson E.N.; Do Carmo S.; Iulita M.F.; BACE1 inhibition by microdose lithium formulation NP03 rescues memory loss and early stage amyloid neuropathology. Transl Psychiatry 2017,7(8)","journal-title":"Transl Psychiatry"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.etap.2018.05.017","volume":"61","author":"Geeva N.S.","year":"2018","unstructured":"Geeva N.S.; Narayan S.; Lithium entrapped chitosan nanoparticles to reduce toxicity and increase cellular uptake of lithium. Environ Toxicol Pharmacol 2018,61,79-86","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=60","first-page":"983","volume":"16","author":"Bruch G.E.","year":"2017","unstructured":"Bruch G.E.; Cordeiro M.F.; Gomides L.S.; Implications of PEGylation of carbon nanotubes for central nervous system bioavailability. CNS Neurol Disord Drug Targets 2017,16(9),983-989","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1083\/jcb.200504035","volume":"170","author":"Sarkar S.","year":"2005","unstructured":"Sarkar S.; Floto R.A.; Berger Z.; Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 2005,170(7),1101-1111","journal-title":"J Cell Biol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"527","DOI":"10.4161\/auto.5923","volume":"4","author":"Fornai F.","year":"2008","unstructured":"Fornai F.; Longone P.; Ferrucci M.; Autophagy and amyotrophic lateral sclerosis: The multiple roles of lithium. Autophagy 2008,4(4),527-530","journal-title":"Autophagy"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.encep.2008.12.007","volume":"35","author":"Le Roy V.","year":"2009","unstructured":"Le Roy V.; Delmas Y.; Verdoux H.; Chronic renal complications induced by lithium. Encephale 2009,35(6),605-610","journal-title":"Encephale"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2515\/therapie\/2009010","volume":"64","author":"Schmitt C.","year":"2009","unstructured":"Schmitt C.; Furet Y.; Perrotin D.; Paintaud G.; Acute lithium intoxications, review of the literature and cases study. Therapie 2009,64(1),55-63","journal-title":"Therapie"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40345-018-0121-0","volume":"6","author":"Kerckhoffs A.P.M.","year":"2018","unstructured":"Kerckhoffs A.P.M.; Hartong E.G.T.M.; Grootens K.P.; The perspectives of patients with lithium-induced end-stage renal disease. Int J Bipolar Disord 2018,6(1),13","journal-title":"Int J Bipolar Disord"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2165\/00002018-199920030-00004","volume":"20","author":"Gitlin M.","year":"1999","unstructured":"Gitlin M.; Lithium and the kidney: An updated review. Drug Saf 1999,20(3),231-243","journal-title":"Drug Saf"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40345-015-0028-y","volume":"3","author":"Azab A.N.","year":"2015","unstructured":"Azab A.N.; Shnaider A.; Osher Y.; Wang D.; Bersudsky Y.; Belmaker R.H.; Lithium nephrotoxicity. Int J Bipolar Disord 2015,3(1),28","journal-title":"Int J Bipolar Disord"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.euroneuro.2014.01.002","volume":"24","author":"Aiff H.","year":"2014","unstructured":"Aiff H.; Attman P.O.; Aurell M.; Bendz H.; Schon S.; Svedlund J.; End-stage renal disease associated with prophylactic lithium treatment. Eur Neuropsychopharmacol 2014,24(4),540-544","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"F1222","DOI":"10.1152\/ajprenal.00321.2005","volume":"290","author":"Nielsen J.","year":"2006","unstructured":"Nielsen J.; Kwon T.H.; Fr\u00f8kiaer J.; Knepper M.A.; Nielsen S.; Lithium-induced NDI in rats is associated with loss of alpha-ENaC regulation by aldosterone in CCD. Am J Physiol Renal Physiol 2006,290(5),F1222-F1233","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1681\/ASN.2010070734","volume":"22","author":"Christensen B.M.","year":"2011","unstructured":"Christensen B.M.; Zuber A.M.; Loffing J.; alphaENaC-mediated lithium absorption promotes nephrogenic diabetes insipidus. J Am Soc Nephrol 2011,22(2),253-261","journal-title":"J Am Soc Nephrol"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.biopha.2016.10.106","volume":"84","author":"El-Sheikh A.A.K.","year":"2016","unstructured":"El-Sheikh A.A.K.; Kamel M.Y.; Ginsenoside-Rb1 ameliorates lithium-induced nephrotoxicity and neurotoxicity: Differential regulation of COX-2\/PGE2 pathway. Biomed Pharmacother 2016,84,1873-1884","journal-title":"Biomed Pharmacother"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1017\/S0033291700053307","volume":"11","author":"Lazarus J.H.","year":"1981","unstructured":"Lazarus J.H.; John R.; Bennie E.H.; Chalmers R.J.; Crockett G.; Lithium therapy and thyroid function: A long-term study. Psychol Med 1981,11(1),85-92","journal-title":"Psychol Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1744-6163.2009.00201.x","volume":"45","author":"Rizwan M.M.","year":"2009","unstructured":"Rizwan M.M.; Perrier N.D.; Long-term lithium therapy leading to hyperparathyroidism: A case report. Perspect Psychiatr Care 2009,45(1),62-65","journal-title":"Perspect Psychiatr Care"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMc1708919","volume":"377","author":"Gutgesell H.","year":"2017","unstructured":"Gutgesell H.; Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med 2017,377(9),893","journal-title":"N Engl J Med"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.dld.2009.07.021","volume":"42","author":"Chadha V.D.","year":"2010","unstructured":"Chadha V.D.; Bhalla P.; Dhawan D.; Uptake and retention of 65Zn in lithium-treated rat liver: Role of zinc. Dig Liver Dis 2010,42(6),446-450","journal-title":"Dig Liver Dis"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1055\/s-0032-1327296","volume":"137","author":"Halboos A.","year":"2012","unstructured":"Halboos A.; Jockenhovel F.; Complete atrioventricular block during lithium therapy within therapeutic range. Dtsch Med Wochenschr 2012,137(49),2583-2585","journal-title":"Dtsch Med Wochenschr"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/JGP.0b013e318172b3d0","volume":"17","author":"Forester B.P.","year":"2009","unstructured":"Forester B.P.; Streeter C.C.; Berlow Y.A.; Brain lithium levels and effects on cognition and mood in geriatric bipolar disorder: A lithium-7 magnetic resonance spectroscopy study. Am J Geriatr Psychiatry 2009,17(1),13-23","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1055\/s-0043-125393","volume":"51","author":"Nielsen R.E.","year":"2018","unstructured":"Nielsen R.E.; Kessing L.V.; Nolen W.A.; Licht R.W.; Lithium and renal impairment: A review on a still hot topic. Pharmacopsychiatry 2018,51(5),200-205","journal-title":"Pharmacopsychiatry"},{"key":"ref=79","author":"Medi\u0107 B.","year":"2018","unstructured":"Medi\u0107 B.; Stojanovi\u0107 M.; \u0160timec B.; Lithium - pharmacological and toxicological aspects: The current state of the art. Curr Med Chem 2018","journal-title":"Curr Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"812","DOI":"10.2174\/1871527315666160801143108","volume":"16","author":"Guidi S.","year":"2017","unstructured":"Guidi S.; Bianchi P.; Stagni F.; Lithium restores age-related olfactory impairment in the Ts65Dn mouse model of down syndrome. CNS Neurol Disord Drug Targets 2017,16(7),812-819","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2174\/1871527316666170505123956","volume":"16","author":"Luo Q.","year":"2017","unstructured":"Luo Q.; Ren Z.; Zhu L.; Involvement of microRNA-146a in the inflammatory response of status Epilepticus Rats. CNS Neurol Disord Drug Targets 2017,16(6),686-693","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2174\/1871527317666180724150839","volume":"17","author":"Jiang X.W.","year":"2018","unstructured":"Jiang X.W.; Lu H.Y.; Xu Z.; \n                        In Silico analyses for key genes and molecular genetic mechanism in epilepsy and Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 2018,17(8),608-617","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1021\/cn500058v","volume":"5","author":"Rapoport S.I.","year":"2014","unstructured":"Rapoport S.I.; Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade. ACS Chem Neurosci 2014,5(6),459-467","journal-title":"ACS Chem Neurosci"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"820","DOI":"10.2174\/1871527316666170207160606","volume":"16","author":"Kamal M.A.","year":"2017","unstructured":"Kamal M.A.; Shakil S.; Nawaz M.S.; Inhibition of butyrylcholinesterase with fluorobenzylcymserine, an experimental Alzheimer\u2019s drug candidate: Validation of enzoinformatics results by classical and innovative enzyme kinetic analyses. CNS Neurol Disord Drug Targets 2017,16(7),820-827","journal-title":"CNS Neurol Disord Drug Targets"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/176673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T08:59:26Z","timestamp":1582102766000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/176673\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":84,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,1,17]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527318666191114095249","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,17]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-04-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}